Results
91
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
91 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.20 | -1.5% | 1.0% | SEK 325.4m | SEK 2.20 | PS2.8x | E86.1% | n/a | Tech | ||
YUBICO | SEK 217.00 | -15.7% | 114.0% | SEK 18.7b | SEK 321.67 | PE96.4x | E42.3% | n/a | Software | ||
CTT | SEK 279.00 | 1.8% | 26.2% | SEK 3.5b | n/a | PE34.3x | E24.8% | 1.9% | Capital Goods | ||
MAGLE | SEK 37.80 | 0.5% | 18.9% | SEK 408.2m | SEK 50.00 | PE53.1x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 37.50 | 4.2% | 2.5% | SEK 12.9b | SEK 57.20 | PE27x | E21.6% | 1.1% | Software | ||
BIOA B | SEK 175.60 | 0.5% | -40.5% | SEK 15.5b | SEK 290.60 | PS51.8x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
FNOX | SEK 62.22 | 3.8% | 6.5% | SEK 38.0b | SEK 77.88 | PE58.4x | E22.6% | 0.3% | Software | ||
BIOVIC B | SEK 2.76 | 4.0% | -58.8% | SEK 231.6m | SEK 6.20 | PS31.2x | E78.5% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.22 | -6.7% | -7.1% | SEK 240.1m | SEK 2.84 | PS2.2x | E115.5% | n/a | Tech | ||
CRAD B | SEK 41.00 | 0.4% | 32.3% | SEK 1.4b | SEK 57.00 | PE25.7x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.08 | 1.0% | -15.6% | SEK 302.2m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CTM | SEK 7.08 | -3.9% | -64.0% | SEK 535.6m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
FLEXQ | SEK 9.36 | -6.2% | -42.6% | SEK 125.5m | SEK 25.00 | PS1.1x | E118.7% | n/a | Capital Goods | ||
EQT | SEK 347.40 | 7.2% | 69.7% | SEK 410.4b | SEK 354.90 | PE120.3x | E35.6% | 1.0% | Diversified Financials | ||
KLAR | SEK 0.74 | 39.6% | 17.8% | SEK 96.0m | SEK 1.00 | PB4.6x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 16.05 | 3.5% | -32.0% | SEK 563.9m | SEK 22.00 | PS1.9x | E108.0% | n/a | Software | ||
SENZA | SEK 7.65 | 4.1% | -6.7% | SEK 225.7m | SEK 16.00 | PS4.1x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 5.04 | -10.2% | 18.9% | SEK 1.5b | SEK 11.40 | PS20.8x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
RUSTA | SEK 75.35 | 11.5% | n/a | SEK 11.4b | SEK 86.00 | PE25.4x | E21.5% | 1.5% | Retail | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.44 | -7.2% | -56.6% | SEK 162.7m | n/a | PS1.7x | E66.8% | n/a | Software | ||
LIME | SEK 325.50 | 3.0% | 27.1% | SEK 4.3b | SEK 366.25 | PE50.3x | E22.7% | 1.1% | Software | ||
RAIL | SEK 30.70 | 0.3% | 68.7% | SEK 740.6m | SEK 34.00 | PE16.9x | E27.0% | 2.3% | Transportation | ||
EG7 | SEK 14.50 | 3.1% | -23.7% | SEK 1.3b | SEK 41.00 | PE30.1x | E65.7% | 3.1% | Media |